Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis
- 1 May 2018
- journal article
- research article
- Published by Springer Nature in Indian Journal of Gastroenterology
- Vol. 37 (3) , 215-225
Abstract
Alcohol-induced intestinal dysbiosis is central to the development of the severe alcoholic liver disease. We present the first study to compare outcomes in patients of severe alcoholic hepatitis (SAH) on nutritional therapy, corticosteroids, pentoxifylline, and healthy donor fecal transplantation (FMT) and discuss distinct microbial community and microbiome metabolic functional changes after FMT.Keywords
This publication has 24 references indexed in Scilit:
- Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With CorticosteroidsGastroenterology, 2016
- Intestinal microbiota contributes to individual susceptibility to alcoholic liver diseaseGut, 2015
- Alcoholic Liver Disease: Role of CytokinesBiomolecules, 2015
- Prednisolone or Pentoxifylline for Alcoholic HepatitisNew England Journal of Medicine, 2015
- Altered profile of human gut microbiome is associated with cirrhosis and its complicationsJournal of Hepatology, 2014
- Branched-chain amino acids in liver diseasesWorld Journal of Gastroenterology, 2013
- Linkage of gut microbiome with cognition in hepatic encephalopathyAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2012
- Strong predictors for alcohol recidivism after liver transplantation: Non-acceptance of the alcohol problem and abstinence of <3 monthsScandinavian Journal of Gastroenterology, 2011
- Characterization of fecal microbial communities in patients with liver cirrhosisHepatology, 2011
- Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient dataGut, 2010